PBYI FY2025 SEC EDGAR DEF 14A #139 of 168 in industry

Puma Biotechnology, Inc. CEO pay ratio

The CEO earned $3.1M in FY2025 against median worker pay of $273,504 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-04-28
Industry
Chemicals & Pharmaceuticals
Industry rank
#139/168

Data updated August 2026

Subscribe to Puma Biotechnology, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
11:1
Below Average (Scale: 0–1000:1)
CEO pay
$3.1M
Median worker
$273,504

Answer first

Puma Biotechnology, Inc.'s FY2025 CEO total of $3.1M ranks #1078 of 1,423 complete filings; its 11:1 pay ratio ranks #1269. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $273,504. Industry placement uses the FY2025 SIC-28 peer cohort (# 139 of 168, 18th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1078
$3.1M of 1,423 FY2025
Ratio rank
#1269
11:1 of 1,423
Industry pct
18th
among the lower quartile of industry peers by pay ratio

How Puma Biotechnology, Inc. ranks nationally

Puma Biotechnology, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$3,062,337 24th percentile higher than 24% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). This entry sits in this band. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Puma Biotechnology, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($3.1M) against pay ratio (11:1) for Puma Biotechnology, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both02072365.44144730.96217096.38289461.87.3:116.4:125.5:134.6:143.6:1CEO total payPay ratio (CEO : median worker)Puma Biotechnology, Inc., CEO total pay: 3062337 · Pay ratio (CEO : median worker): 11:1Puma Biotechnology, Inc.Lifecore Biomedical, Inc. \de\, CEO total pay: 6547620 · Pay ratio (CEO : median worker): 12:1Lifecore Biomedical, Inc. \de\Cumberland Pharmaceuticals Inc, CEO total pay: 101000 · Pay ratio (CEO : median worker): 10:1Cumberland Pharmaceuticals IncLexicon Pharmaceuticals, Inc., CEO total pay: 3553953 · Pay ratio (CEO : median worker): 13:1Lexicon Pharmaceuticals, Inc.Acadia Pharmaceuticals Inc, CEO total pay: 2574405 · Pay ratio (CEO : median worker): 9:1Acadia Pharmaceuticals IncAmylyx Pharmaceuticals, Inc., CEO total pay: 2685240 · Pay ratio (CEO : median worker): 9:1Amylyx Pharmaceuticals, Inc.
Puma Biotechnology, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Puma Biotechnology, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Puma Biotechnology, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
11:1
FY2025
vs prior FY
-4:1
from FY2024 15:1
CEO $ YoY
-23%
$3.1M latest
Filings shown
4
FY2022–2025
Puma Biotechnology, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2022 $243K - $243,139 10:1 -
2023 $2.9M +1111% $258,589 11:1 +1:1
2024 $4.0M +35% $260,734 15:1 +4:1
2025 $3.1M -23% $273,504 11:1 -4:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1401667, FY2022–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
11:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$3.1M
Companies in Industry
168
vs. Industry Median
Below
#139 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Puma Biotechnology, Inc.: near-parity Item 402(u) ratio

Puma Biotechnology, Inc.'s FY2025 ratio 11:1 ranks #139 of 168 Chemicals & Pharmaceuticals filers (18th percentile). the CEO earned 11× the median employee ($273,504) in FY2025.

At $273,504 median worker pay, the FLOOR stamp is near pay-parity territory under MID$ CEO total.

CEO Total Pay

$3.1M

FY2025 Summary Compensation, below median

Pay Ratio

11:1

Below typical

Puma Biotechnology, Inc. in the lower Chemicals & Pharmaceuticals third

Puma Biotechnology, Inc.'s FY2025 ratio 11:1 ranks #139 of 168 Chemicals & Pharmaceuticals filers (18th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Puma Biotechnology, Inc.'s $3.1M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1078 and ratio rank #1269 split - treat 11:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$3.1M
Median Employee Pay
$273,504
Pay Ratio
11:1
Filing Date
2026-04-28

Company Info

Ticker
PBYI
CIK
1401667
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1401667, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Puma Biotechnology, Inc.'s FY2025 ratio 11:1 ranks #139 of 168 Chemicals & Pharmaceuticals filers (18th percentile).

Read with Puma Biotechnology, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MID$ · ELITE-MED.

El Pollo Loco Holdings, Inc. · MID$

ABS(ceo_total_comp) peer at $3.1M (Δ $169 heavier vs Puma Biotechnology, Inc.); STEEP · LOW-MED vs this page's FLOOR · MID$ · ELITE-MED.
Mission Produce, Inc. · MID$

ABS(ceo_total_comp) peer at $3.1M (Δ $10K lighter vs Puma Biotechnology, Inc.); EXTREME · LOW-MED vs this page's FLOOR · MID$ · ELITE-MED.
Lifetime Brands, Inc · MID$

ABS(ceo_total_comp) peer at $3.0M (Δ $24K lighter vs Puma Biotechnology, Inc.); MODEST · PAR-MED vs this page's FLOOR · MID$ · ELITE-MED.
Turning Point Brands, Inc. · MID$

ABS(ceo_total_comp) peer at $3.0M (Δ $26K lighter vs Puma Biotechnology, Inc.); MODEST · HIGH-MED vs this page's FLOOR · MID$ · ELITE-MED.
Lifecore Biomedical, Inc. \de\ (SIC 28 pole)

Lifecore Biomedical, Inc. \de\ stamps FLOOR · HEAVY nearest in-SIC by ABS(pay_ratio) to Puma Biotechnology, Inc.'s FLOOR filing.
National dual ranks · #1078/#1269

Puma Biotechnology, Inc.'s FY2025 package sits #1078 by CEO dollars and #1269 by ratio under MID$ · FLOOR.
Ratio primer · FLOOR

Puma Biotechnology, Inc.'s FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Puma Biotechnology, Inc. (CIK 1401667), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.